Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting
Version 3 2024-06-18, 18:38Version 3 2024-06-18, 18:38
Version 2 2024-06-03, 16:29Version 2 2024-06-03, 16:29
Version 1 2019-01-01, 00:00Version 1 2019-01-01, 00:00
journal contribution
posted on 2024-06-18, 18:38authored byNL Messina, K Gardiner, S Donath, K Flanagan, AL Ponsonby, F Shann, R Robins-Browne, B Freyne, V Abruzzo, C Morison, L Cox, S Germano, C Zufferey, P Zimmermann, KJ Allen, Peter VuillerminPeter Vuillermin, M South, D Casalaz, N Curtis
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting